India, Oct. 13 -- Drug major Johnson & Johnson on Tuesday reported sharply lower third-quarter profit mainly on special charge related to proposed talc litigation, despite sales growth. Further, the firm raised its fiscal 2026 outlook again and announced a quarterly dividend.
In pre-market activity, the shares were losing around 2.6 percent, trading at $257.14, after closing Monday's regular trading 0.88 percent higher.
For fiscal 2026, the company increased adjusted earnings per share guidance by $0.06 to $11.10 or 2.9 percent at the midpoint, with estimated reported sales of $101.2 billion or 7.4 percent at the midpoint.
Looking ahead for fiscal 2026, the company now projects adjusted earnings in a range of $11.05 to $11.15 per share, ...